Published in J R Soc Med on June 01, 2008
Medicines and the media: news reports of medicines recommended for government reimbursement in Australia. BMC Public Health (2013) 0.83
Ethics, evidence and economics in the pursuit of "personalized medicine". J Pers Med (2014) 0.82
Trick or treat? Australian newspaper portrayal of complementary and alternative medicine for the treatment of cancer. Support Care Cancer (2009) 0.79
Consumer beware: a systematic assessment of potential bias in the lay electronic media to examine the portrayal of "PARP" inhibitors for cancer treatment. J Cancer Educ (2011) 0.77
Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study. J Pharm Policy Pract (2015) 0.77
The media and access issues: content analysis of Canadian newspaper coverage of health policy decisions. Orphanet J Rare Dis (2015) 0.75
Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia. PLoS One (2017) 0.75
Attention Deficit Hyperactivity Disorder on YouTube: Framing, Anchoring, and Objectification in Social Media. Community Ment Health J (2016) 0.75
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med (2005) 33.60
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med (2005) 28.25
Selling sickness: the pharmaceutical industry and disease mongering. BMJ (2002) 10.98
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. N Engl J Med (2006) 9.85
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet (2007) 9.24
Randomized trials stopped early for benefit: a systematic review. JAMA (2005) 8.43
Coverage by the news media of the benefits and risks of medications. N Engl J Med (2000) 7.50
Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue. JAMA (1991) 6.11
Mass media interventions: effects on health services utilisation. Cochrane Database Syst Rev (2002) 4.75
The trouble with medical journals. J R Soc Med (2006) 4.28
Herceptin and early breast cancer: a moment for caution. Lancet (2005) 4.13
Drugs for exceptionally rare diseases: do they deserve special status for funding? QJM (2005) 3.27
How much will Herceptin really cost? BMJ (2006) 3.23
Adjuvant trastuzumab for breast cancer. BMJ (2005) 2.98
The rule of rescue. Soc Sci Med (2003) 2.63
Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol (2007) 2.33
Changes to the Pharmaceutical Benefits Advisory Committee. Med J Aust (2001) 2.14
A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. J Clin Oncol (2007) 2.09
A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model-based cost-effectiveness analysis. Ann Oncol (2005) 1.83
Bentham in a box: technology assessment and health care allocation. Law Med Health Care (1986) 1.75
How NICE may be outflanked. BMJ (2006) 1.61
An economic evaluation of Herceptin in adjuvant setting: the Breast Cancer International Research Group 006 trial. Ann Oncol (2005) 1.56
Health news and the American public, 1996-2002. J Health Polit Policy Law (2003) 1.44
Bentham in a box--technology assessment and the artificial heart. West J Med (1986) 1.41
Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario. CMAJ (2001) 1.40
Cancer in the mass print media: fear, uncertainty and the medical model. Soc Sci Med (2006) 1.39
Unhealthy spin. BMJ (2003) 1.25
External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer. BMC Cancer (2007) 1.08
Access to high cost drugs in Australia. BMJ (2004) 1.07
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab? J Clin Oncol (2007) 1.03
Coverage of breast cancer in the Australian print media--does advertising and editorial coverage reflect correct social marketing messages? J Health Commun (2004) 1.03
The role of the media in steering public opinion on healthcare issues. Health Policy (2003) 1.00
Cost effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a lifetime model. Pharmacoeconomics (2007) 0.98
Tailoring access to high cost, genetically targeted drugs. Med J Aust (2005) 0.94
Questions about adjuvant trastuzumab still remain. Lancet (2007) 0.92
'A matter of faith, not science': analysis of media coverage of prostate cancer screening in Australian news media 2003-2006. J R Soc Med (2007) 0.88
A comparison of breast, testicular and prostate cancer in mass print media (1996-2001). Soc Sci Med (2004) 0.88
An analysis of newspaper reports of cancer breakthroughs: hope or hype? Med J Aust (2003) 0.87
Ethnicity, genetics, and breast cancer: media portrayal of disease identities. Ethn Health (2005) 0.86
Measuring economic outcomes of cancer. J Natl Cancer Inst Monogr (2004) 0.86
Fury as Australia appoints former industry lobbyist to drugs watchdog. BMJ (2001) 0.85
Patient demand and politics push Herceptin forward. CMAJ (2005) 0.83
The Australian health news research collaboration. Med J Aust (2007) 0.83
Trastuzumab (Herceptin) and HER2-positive breast cancer. CMAJ (2006) 0.77
Impact of tobacco control policies and mass media campaigns on monthly adult smoking prevalence. Am J Public Health (2008) 3.72
Impact of news of celebrity illness on breast cancer screening: Kylie Minogue's breast cancer diagnosis. Med J Aust (2005) 2.87
Model of outcomes of screening mammography: information to support informed choices. BMJ (2005) 2.86
Questionable inflated estimate of smoking prevalence among mentally ill persons in Australia. Aust N Z J Psychiatry (2008) 2.42
Is censorship of films a useful solution to the problem of covert tobacco advertising? (with response by Maubach et al). N Z Med J (2013) 2.36
Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med (2007) 2.10
Is "YouTube" telling or selling you something? Tobacco content on the YouTube video-sharing website. Tob Control (2007) 2.06
The case for the plain packaging of tobacco products. Addiction (2008) 2.03
"Bulletproof skeptics in life's jungle": which self-exempting beliefs about smoking most predict lack of progression towards quitting? Prev Med (2004) 1.87
"The news is [not] all good": misrepresentations and inaccuracies in Australian news media reports on prostate cancer screening. Med J Aust (2007) 1.81
Communicating about screening. BMJ (2008) 1.74
British American Tobacco on Facebook: undermining Article 13 of the global World Health Organization Framework Convention on Tobacco Control. Tob Control (2010) 1.57
From "our world" to the "real world": Exploring the views and behaviour of policy-influential Australian public health researchers. Soc Sci Med (2011) 1.55
The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) (2009) 1.48
Time to legislate for fire-safe cigarettes in Australia. Med J Aust (2004) 1.47
Framing pub smoking bans: an analysis of Australian print news media coverage, March 1996-March 2003. J Epidemiol Community Health (2005) 1.43
Mental health and smoking redux. Aust N Z J Psychiatry (2009) 1.42
Gun control. Australian and US gun deaths compared. BMJ (2011) 1.42
Is a smoking ban in UK parks and outdoor spaces a good idea? BMJ (2015) 1.39
Declines in Australian suicide: a reanalysis of Mcphedran and Baker (2008). Health Policy (2008) 1.38
Banning smoking in cars carrying children: an analytical history of a public health advocacy campaign. Aust N Z J Public Health (2008) 1.34
Health treaty dilution: a case study of Japan's influence on the language of the WHO Framework Convention on Tobacco Control. J Epidemiol Community Health (2006) 1.28
What maintains parental support for vaccination when challenged by anti-vaccination messages? A qualitative study. Vaccine (2006) 1.28
Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry. Lancet (2005) 1.24
Informed choice for screening: implications for evaluation. BMJ (2006) 1.22
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost (2014) 1.21
Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer. Value Health (2008) 1.21
Benefits and risks in ending regulatory exceptionalism for tobacco. Tob Control (2008) 1.21
Press-released papers are more downloaded and cited. Tob Control (2007) 1.15
Getting evidence into policy: The need for deliberative strategies? Soc Sci Med (2011) 1.15
Smokers and non-smokers talk about regulatory options in tobacco control. Tob Control (2006) 1.08
Can even minimal news coverage influence consumer health-related behaviour? A case study of iodized salt sales, Australia. Health Educ Res (2007) 1.08
Falling prevalence of smoking: how low can we go? Tob Control (2007) 1.08
The association between four citation metrics and peer rankings of research influence of Australian researchers in six fields of public health. PLoS One (2011) 1.07
Butt clean up campaigns: wolves in sheep's clothing? Tob Control (2006) 1.06
Enhancing citizen engagement in cancer screening through deliberative democracy. J Natl Cancer Inst (2013) 1.05
Galvanizers, guides, champions, and shields: the many ways that policymakers use public health researchers. Milbank Q (2011) 1.04
Is it worth the risk? A systematic review of instruments that measure risk propensity for use in the health setting. Soc Sci Med (2005) 1.03
An analysis of media coverage on the prevention and early detection of CKD in Australia. Am J Kidney Dis (2008) 1.01
High participation rates are not necessary for cost-effective colorectal cancer screening. J Med Screen (2005) 0.99
Tobacco control advocacy in the age of social media: using Facebook, Twitter and change. Tob Control (2012) 0.99
Validity, responsiveness, and minimal important difference for the SF-6D health utility scale in a spinal cord injured population. Value Health (2008) 0.98
Identifying trustworthy experts: how do policymakers find and assess public health researchers worth consulting or collaborating with? PLoS One (2012) 0.97
Are cancer drugs less likely to be recommended for listing by the Pharmaceutical Benefits Advisory Committee in Australia? Pharmacoeconomics (2010) 0.97
Assessing decision quality in patient-centred care requires a preference-sensitive measure. J Health Serv Res Policy (2013) 0.97
A bibliometric analysis of research on Indigenous health in Australia, 1972-2008. Aust N Z J Public Health (2012) 0.95
Political dynamics promoting the incremental regulation of secondhand smoke: a case study of New South Wales, Australia. BMC Public Health (2006) 0.95
Communicating uncertainty--how Australian television reported H1N1 risk in 2009: a content analysis. BMC Public Health (2011) 0.95
The future of smoke-free legislation. BMJ (2007) 0.94
'The cold hard facts' immunisation and vaccine preventable diseases in Australia's newsprint media 1993-1998. Soc Sci Med (2002) 0.94
Secondhand smoke exposure levels in outdoor hospitality venues: a qualitative and quantitative review of the research literature. Tob Control (2012) 0.93
Measuring interactivity on tobacco control websites. J Health Commun (2012) 0.93
Measuring patient preference and surgeon choice. Surgery (2008) 0.92
International tobacco control should repudiate Jekyll and Hyde health philanthropy. Tob Control (2008) 0.92
Sex and drugs in popular movies: an analysis of the top 200 films. J R Soc Med (2005) 0.92
Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screening. Patient (2011) 0.92
Estimates and determinants of economic impacts from influenza-like illnesses caused by respiratory viruses in Australian children attending childcare: a cohort study. Influenza Other Respir Viruses (2013) 0.91
Legal action by Big Tobacco against the Australian government's plain packaging law. Tob Control (2012) 0.91
Nicotine analogues: a review of tobacco industry research interests. Addiction (2005) 0.91
Quitting smoking and gaining weight: the odd couple. BMJ (2012) 0.90
Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer. Arch Surg (2008) 0.90
Australian television news coverage of alcohol, health and related policies, 2005 to 2010: implications for alcohol policy advocates. Aust N Z J Public Health (2012) 0.89
Implementing patient decision support tools: moving beyond academia? Patient Educ Couns (2009) 0.89
HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility? Health Econ (2008) 0.89
'A matter of faith, not science': analysis of media coverage of prostate cancer screening in Australian news media 2003-2006. J R Soc Med (2007) 0.88
Mixed messages and a missed opportunity: Australian news media coverage of Clare Oliver's campaign against solaria. Med J Aust (2008) 0.88
Advocates, interest groups and Australian news coverage of alcohol advertising restrictions: content and framing analysis. BMC Public Health (2012) 0.87
An analysis of newspaper reports of cancer breakthroughs: hope or hype? Med J Aust (2003) 0.87
What should be done about policy on alcohol pricing and promotions? Australian experts' views of policy priorities: a qualitative interview study. BMC Public Health (2013) 0.86
Workplace exposure to secondhand smoke and its association with respiratory symptoms--a cross-sectional study among workers in Shanghai. Tob Control (2010) 0.86
'A disease many people still feel uncomfortable talking about': Australian television coverage of colorectal cancer. Psychooncology (2010) 0.86
Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis. Value Health (2009) 0.85
Workplace smoking policies and their association with male employees' smoking behaviours: a cross-sectional survey in one company in China. Tob Control (2010) 0.85
The growth in newspaper coverage of tobacco control in China, 2000-2010. BMC Public Health (2012) 0.85
Preferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: a discrete choice experiment. Value Health (2011) 0.85
Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) Trial [ISRCTN44485060]. BMC Pregnancy Childbirth (2006) 0.85
Framing and the marginalisation of evidence in media reportage of policy debate about alcopops, Australia 2008-2009: implications for advocacy. Drug Alcohol Rev (2010) 0.85
Group Carso, health philanthropy, and tobacco. Lancet (2008) 0.85
Surgical and oncology trials for rectal cancer: who will participate? Surgery (2007) 0.84
Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study. BMC Public Health (2013) 0.84
Forecasting future tobacco control policy: where to next? Aust N Z J Public Health (2010) 0.84
The lightest market in the world: light and mild cigarettes in Japan. Nicotine Tob Res (2008) 0.83
The Australian health news research collaboration. Med J Aust (2007) 0.83
Blinding of reviewers and authors. Aust N Z J Public Health (2003) 0.83
Improving Quality of Life for People with Incurable Large-Bowel Obstruction: Randomized Control Trial of Colonic Stent Insertion. Dis Colon Rectum (2015) 0.83
The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia. Sex Health (2006) 0.82
Smoking-related disease on Australian television news: inaccurate portrayals may contribute to public misconceptions. Aust N Z J Public Health (2009) 0.82
There's nothing that succeeds like failure: discerning the woods from the trees in smoking cessation debates. Nicotine Tob Res (2012) 0.81
Digital junk: food and beverage marketing on Facebook. Am J Public Health (2014) 0.80
The newsworthiness of cancer in Australian television news. Med J Aust (2008) 0.80
Room for improvement: mixed portrayal of young people with mental illness on Australian television news. Aust N Z J Psychiatry (2010) 0.79
Generating news media interest in tobacco control; challenges in an advanced policy environment. Health Promot J Austr (2012) 0.79
Impact of Australian celebrity diagnoses on prostate cancer screening. Med J Aust (2009) 0.79